Please login to the form below

Not currently logged in
Email:
Password:

Pfizer’s Alan Maine moves to Edelman

He joins the communications firm as its senior director

Alan MaineGlobal communications and marketing firm Edelman has strengthened its health public affairs capabilities with the addition of Alan Maine, who joins as its senior director.

Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area public affairs.

During his time at Pfizer, Maine also worked with industry associations on campaigns, policies and initiatives relating to access to medicines.

He said: “I am delighted to be working with such a forward-looking company as Edelman and I am thrilled to work with the team to deliver innovative and strategic campaigns.”

Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals - later acquired by Pfizer - and has held other roles with Merck Sharpe & Dohme.

Kate Hawker, managing director for Edelman UK, said: “We are very excited about Alan joining Edelman as he brings with him such great knowledge and insight of the complex challenges in the UK.”

5th February 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics